OVERVIEW | TEAM | NEWS

Team

An expert team of bioprocessing scientists and industry leaders who are deeply engaged in the scientific pursuit of growing a platform biotechnology company that enables next-generation biopharmaceutical manufacturing technologies to impact patients’ lives.

MANAGEMENT TEAM

Kevin Isett, PhD

Chief Executive Officer, CoFounder

bio

Adimab – Head of High Throughput Manufacturing Merck – 10+ Years with Merck Biologics & Vaccines Research and Bioprocess R&D Merck – Senior Engineer at Merck Bioprocess R&D, Automated & High-throughput Bioprocess Technologies Dartmouth College, Thayer Engineering School – Merck-Sponsored Doctoral Fellow

Warren Kett, PhD

Chief Scientific Officer, CoFounder

bio

Dartmouth College, Thayer Engineering School – Senior Research Fellow Glycan Biosciences – Co-Founder and CTO GlycoFi (Acquired by Merck in 2006) – Senior Chemist

Scott Kennedy

Chief Financial Officer

bio

20+ years in executive life science finance operations PerkinElmer McGladrey & Pullen University of Minnesota

Kimberly Cornwell

General Counsel

bio

Outside GC

Sanofi Pasteur

Acambis

Edwards and Angell

Boston University School of Law

Karol Lacki, PhD

VP Technology Development

bio

20+ years in developing and modeling biopharmaceutical separation technologies and manufacturing processes Novo Nordisk A/S – Director Mathematical Modeling GE Healthcare Life Sciences – Customer Collaboration Leader Amersham Pharmacia Biotech – Polymer and Surface Chemistry